In a few decades, gene-editing technologies could reduce the likelihood of common human diseases. Societies must use this ...

A new technology, mvGPT, is capable of precisely editing genes, activating gene expression, and repressing genes all at the ...

The adenine base editor corrected the most common mutation associated with Stargardt disease in the ABCA4 gene with no off-target effects.

Treatments for rare diseases are hard to create and expensive to deliver, but there is new hope for editing the software of ...

The core components of CRISPR-based genome-editing therapies are bacterial proteins called nucleases that can stimulate ...

He wanted to be ‘immortal’ and was ready to risk it all by altering his genome, i.e., the very ... well, peculiar. Human gene editing is a technique that allows the deliberate alteration ...

Caribou has initiated the GALLOP Phase 1 clinical trial, an open-label, multicenter clinical trial designed to evaluate a single infusion of CB-010 in adult patients with LN and ERL. CB-011, a ...

Analyst Yanan Zhu from Wells Fargo maintained a Buy rating on Metagenomi, Inc. (MGX – Research Report) and keeping the price target at ...

Tune Therapeutics, an epigenome-editing company with origins at Duke University, has raised over $175 million in financing to advance a potential treatment for chronic hepatitis B and other diseases.

The biotech plans to use the funding to advance clinical testing of an epigenetic silencing therapy it hopes could treat ...

Colossal Biosciences, which aims to revive extinct species, announced it has raised an additional $200 million. Critics say ...